Results 81 to 90 of about 21,457 (218)

Intrapetrous internal carotid artery dissection and essential thrombocythemia: what relationship? A case report. [PDF]

open access: yes, 2008
Internal carotid artery (ICA) dissection is responsible for 10–20% of strokes in young and middleaged patients. Isolated ICA dissection involving the intrapetrous carotid canal is particularly rare, and no case has been reported to describe an ...
Gargiulo G   +18 more
core   +1 more source

Essential thrombocythemia and acute myocardial infarction treated with rescue coronary angioplasty

open access: yesArquivos Brasileiros de Cardiologia, 1999
A 48-year-old man with essential thrombocythemia suffered an extensive anterior acute myocardial infarction; this is a rare association. A pharmacological thrombolysis was performed, without success.
Antonio Esteves Fº   +4 more
doaj   +1 more source

This Is Not a Myeloproliferative Neoplasm…

open access: yes
Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
Stephanie Juané Kennedy
wiley   +1 more source

Pretreatment with Hydroxyurea of the Patient with Essential Thrombocythemia Followed by Coronary Artery Bypass Surgery

open access: yesOman Medical Journal, 2014
The risk of thrombosis is high in patients with essential thrombocythemia. Special precaution needed for those patients who will undergo Coronary artery bypass grafting. We are reporting a 62 years old patient with ischemic heart disease who was found to
Edem Ziadinov   +3 more
doaj   +1 more source

Calreticulin Type 26 Mutation in Myelofibrosis: A Rare Variant With Diagnostic Challenges

open access: yesJournal of Clinical Laboratory Analysis, Volume 40, Issue 11, June 2026.
ABSTRACT Background Myeloproliferative neoplasms (MPNs) are clonal hematologic disorders commonly driven by mutations in JAK2, MPL, or CALR. Because routine CALR assays are largely optimized for the canonical Type 1 and Type 2 exon 9 variants, rare noncanonical mutations may be missed, creating diagnostic challenges.
Teresa Maltese   +6 more
wiley   +1 more source

Essential Thrombocythemia

open access: yes, 2002
peripheral smear of essential thrombocythemia (ET ...
Lawrence, Christine
core  

Clonal evolution process from essential thrombocythemia to acute myeloid leukemia in the original patient from whom the CALR-mutated Marimo cell line was established [PDF]

open access: yes
We previously reported the Marimo cell line, which was established from the bone marrow cells of a patient with essential thrombocythemia (ET) at the last stage after transformation to acute myeloid leukemia (AML).
Ishikawa, Yuichi   +6 more
core   +1 more source

Single‐Agent Selinexor Versus Physician's Choice in Previously Treated Myelofibrosis: Results From the Phase 2 XPORT‐035 Study

open access: yeseJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT Background Janus kinase inhibitors (JAKis), the current standard of care for myelofibrosis (MF), provide clinical benefit, but responses are frequently incomplete, non‐durable, and associated with cytopenias, underscoring the need for therapies with novel mechanisms of action.
Sebastian Grosicki   +15 more
wiley   +1 more source

Atypical Myocardial Infarction with Apical Thrombus and Systemic Embolism: A Rare Presentation of Likely JAK2 V617F-Positive Myeloproliferative Neoplasm

open access: yesCase Reports in Oncological Medicine, 2020
A few types of myeloproliferative neoplasms may be significant for Janus-associated kinase 2 mutation, JAK2 V617F, including polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Muhammed Atere   +4 more
doaj   +1 more source

Walsh & Hoyt: Essential Thrombocythemia

open access: yes, 2005
Essential thrombocythemia (primary thrombocythemia, hemorrhagic thrombocythemia, idiopathic thrombocythemia) is a chronic myeloproliferative disorder in which the predominant laboratory feature is a persistent, striking thrombocytosis with elevation of ...
John Kerrison, MD
core  

Home - About - Disclaimer - Privacy